Alpha DNA Investment Management’s Rithm Capital RITM Stock Holding History
Bought
Maintained
Sold
Other funds holding RITM
SOMRS
Alpha DNA Investment Management's RITM Position: Q1 2025 in Review
Alpha DNA Investment Management sold out of Rithm Capital (RITM) in Q1 2025, closing a stake of 37,188 shares — an estimated $403K sold.
Alpha DNA Investment Management first reported a position in RITM in Q2 2024 and held it in 3 quarters. The position peaked at $403K in Q4 2024. 501 funds tracked by Wall St. Rank hold RITM as of Q1 2025.
- Alpha DNA Investment Management reported no remaining Rithm Capital position as of Q1 2025 after selling out during the quarter.
- Alpha DNA Investment Management sold 37,188 Rithm Capital shares in Q1 2025, an estimated $403K.
- Alpha DNA Investment Management first reported a position in Rithm Capital in Q2 2024 and held it in 3 quarters.
- Alpha DNA Investment Management's Rithm Capital position peaked at $403K in Q4 2024.
- 501 funds tracked by Wall St. Rank held Rithm Capital as of Q1 2025.
Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.